DHLRI Historic Timeline

Thomas J. Hund, PhD is named Director of the Davis Heart and Lung Research Institute.

The DHLRI Received a $5.5 million gift from the William H. Davis, Dorothy M. Davis, and William C. Davis Foundation to support research, creating an endowed chair and name the Institute's research unit in the Interdisciplinary Research Facility. 

2021

At the forefront of the global COVID-19 response, DHLRI continued to play an active role in fighting COVID-19. Repurposing lab space for COVID testing, countless numbers of samples from around the state were processed. 

Personnel volunteered to create almost 400,000 virus transport media (VTM) tubes which were used throughout Ohio and nationwide. 

DHLRI administration assists in the herculean effort to help process public vaccines for those 80 and older. 

 2020 

DHLRI celebrates their 20th Anniversary, virtually. With the increase in COVID-19 positivity, the event was held through zoom. 

Joe and Linda Chlapaty make a $15 million commitment to further atrial fibrillation research.
https://wexnermedical.osu.edu/ways-to-give/chlapaty

The 35,000-square-foot Bob and Corrine Frick Center for Heart Failure and Arrhythmia is opened—a first-of-its-kind center in the nation
https://wexnermedical.osu.edu/ways-to-give/bob-and-corrine-frick

The Davis Heart and Lung Research Institute expands, adding six sites for a total space footprint of >200,000 square feet.

Philanthropic support grows 90% in just four years (since 2013).

Biomedical engineer Thomas Hund, PhD, named associate director of the Davis Heart and Lung Research Institute.

The Davis Heart and Lung Research Institute encompasses 700+ faculty, staff and trainees from nine colleges and 26 departments/divisions around Ohio State.

More than 680 grants are submitted, an increase of 430% in six years (from 2010).

Faculty produced 500 articles on basic and translational research in top-tier journals, spanning subjects from molecules to humans, resulting in more than 200 clinical research trials in cardiovascular and pulmonary medicine.

Ross Heart Hospital Wellness Series and TriFit Challenge Triathlon events established, with proceeds going directly to the Davis Heart and Lung Research Institute for research into early detection of heart disease.

Davis Heart and Lung Research Institute expands to more than 600 faculty, staff and trainees.

The Connor Senn Memorial Soccer Match and Symposium on Sudden Cardiac Death in Athletes is launched.

Peter Mohler, PhD, is named director of the Davis Heart and Lung Research Institute.

The Ohio State Cardiac Research Tissue Program is started, providing diseased and healthy human heart tissue for researchers, with more than 200 human hearts procured to date.

Thomas Ryan, MD, joins the Ohio State Heart and Vascular Center as director. He is appointed the physician-scientist leader for the Wexner Medical Center’s Heart program, which unites the Davis Heart and Lung Research Institute and the Ross Heart Hospital under one director.

For the first time, Ohio State’s Heart and Lung programs are ranked on U.S. News & World Report’s “Best Hospitals” list.

An Ohio State University research facility satellite office is established in the Davis Heart and Lung Research Institute.

The Ohio State Department of Surgery and the Davis Heart and Lung Research Institute host the first conference in the United States to address the potential role of oxygen in wound care. This international conference focuses on oxygen sensing, oxidant signaling, oxygen therapeutics, gene therapy, angiogenesis, inflammation, and clinical care.

Ground is broken on the Richard M. Ross Heart Hospital, the sister clinical institution to the Davis Heart and Lung Research Institute for research and translational care.
https://wexnermedical.osu.edu/ways-to-give/in-memory-of-libby-ross

Jay Zweier, MD, PhD, is named director of the Davis Heart and Lung Research Institute.

The Ohio State Heart and Lung Research Institute opens as a 96,000-square-foot free-standing building, one of the largest and most comprehensive institutes in the country devoted to cardiovascular, pulmonary, renal and metabolic disease.

The Ohio State Heart and Lung Research Institute is renamed the Dorothy M. Davis Heart and Lung Research Institute, as approved by the university Board of Trustees upon receiving a $1 million endowment and a $10 million gift.